The Oxidation Crisis: How PUFAs Fuel Chronic Inflammation

Overview

At the heart of the contemporary chronic disease epidemic lies a biochemical paradox: polyunsaturated fatty acids (PUFAs), long championed by public health bodies like the UK’s Scientific Advisory Committee on Nutrition (SACN) as cardioprotective, are fundamentally unstable molecules. When integrated into human cell membranes and low-density lipoproteins (LDLs), these multi-unsaturated structures—characterised by methylene-interrupted double bonds—act as a metabolic Trojan horse. The oxidation crisis is not merely a theoretical construct of lipid peroxidation; it is an ongoing, sub-clinical pathology driven by the mass displacement of stable, saturated and monounsaturated fatty acids by industrial seed oils rich in omega-6 linoleic acid.

To innerstand the systemic consequences of this dietary shift, one must examine the kinetics of lipid peroxidation at a molecular level. The presence of bis-allylic methylene carbons renders PUFAs exquisitely vulnerable to free radical attack. According to landmark pharmacokinetic data published in journals such as The Lancet and Free Radical Biology and Medicine, hydrogen abstraction from these vulnerable sites initiates a self-propagating chain reaction. This cascade generates highly reactive electrophilic aldehydes, most notably malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). These lipid peroxidation products do not remain inert within the lipid bilayer; they covalently modify cellular proteins and DNA, triggering chronic oxidative stress and upregulating nuclear factor kappa B (NF-$\kappa$B) pathways. The resultant transcription of pro-inflammatory cytokines—including tumour necrosis factor-alpha (TNF-$\alpha$) and interleukin-6 (IL-6)—establishes a baseline of low-grade, systemic inflammation that underpins endothelial dysfunction, metabolic syndrome, and atherosclerosis.

From an evolutionary standpoint, the human genome is poorly adapted to handle the unprecedented hyper-concentration of dietary linoleic acid characteristic of the modern Western diet. Historically, ancestral hunter-gatherer populations ingested an omega-6 to omega-3 ratio approaching 1:1 or 2:1. Today, data across the UK population indicates a skewed ratio exceeding 15:1 or even 20:1, largely mediated through the ubiquitous use of refined soybean, corn, and sunflower oils in ultra-processed foods (UPFs). When these labile fats are subjected to the thermal processing inherent in industrial food manufacturing and domestic cooking, primary and secondary oxidation products are formed ex vivo before consumption even occurs. Once ingested, these pre-oxidised lipids exacerbate endogenous oxidative burdens, overwhelming cellular antioxidant defense systems such as glutathione peroxidase and superoxide dismutase. Consequently, cell membranes lose their biophysical fluidity, transmembrane receptor signaling becomes aberrant, and mitochondrial respiration is impaired. This section establishes the foundational thesis for INNERSTANDIN readers: chronic inflammation is not an idiopathic failure of the immune system, but a predictable, chemically mediated consequence of cellular architecture compromised by oxidised industrial PUFAs.

The Biology — How It Works

To comprehend the pathological trajectory of industrial seed oils, one must first examine the fundamental thermodynamic and biochemical vulnerabilities of polyunsaturated fatty acids (PUFAs). Unlike saturated and monounsaturated fatty acids, which possess zero or single methylene-interrupted double bonds respectively, omega-6 PUFAs—predominantly linoleic acid (LA)—contain multiple bis-allylic methylene carbons. These specific structural configurations render the hydrogen atoms bonded to them extraordinarily susceptible to abstraction. As documented extensively in literature via PubMed repositories, the bond dissociation energy of these bis-allylic hydrogens is significantly lower than that of standard aliphatic chains, acting as an electrochemical ticking clock within human cell membranes.

When ingested in the hyper-concentrated quantities characteristic of the modern Western diet—a systemic shift tracked closely by the UK's Scientific Advisory Committee on Nutrition (SACN)—these fragile lipids are incorporated directly into phospholipid bilayers throughout systemic vasculature, hepatic tissue, and neural architecture. Herein lies the core mechanistic failure of the oxidation crisis: cellular membrane fluidity becomes a liability. Upon encountering reactive oxygen species (ROS) generated by normal mitochondrial respiration or exogenous xenobiotics, a self-propagating chain reaction of lipid peroxidation is initiated.

This non-enzymatic cascade proceeds through three distinct phases: initiation, propagation, and termination. During propagation, peroxyl radicals attack adjacent unsaturated lipids, creating a compounding molecular domino effect that degrades membrane integrity. More critically, this degradation yields highly reactive, cytotoxic secondary aldehydes, most notably malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). These electrophilic end-products do not merely dissipate; they form covalent adducts with cellular proteins, structural enzymes, and nuclear DNA. By alkylating critical residues on proteins involved in antioxidant defence—such as thioredoxin reductase—4-HNE disables the cell's endogenous compensatory mechanisms, locking the tissue into a permanent state of oxidative distress.

Simultaneously, the enzymatic oxidation of excess intracellular arachidonic acid (derived metabolically from dietary linoleic acid) by cyclooxygenase (COX) and lipoxygenase (LOX) pathways hyper-activates inflammatory signalling cascades. This biochemical shunt upregulates the synthesis of pro-inflammatory eicosanoids—including 2-series prostaglandins and 4-series leukotrienes—which orchestrate chronic, low-grade systemic inflammation. At INNERSTANDIN, our analysis of these pathways demonstrates that the ingestion of oxidised and oxidation-prone PUFAs acts as a dual-threat catalyst: it physically damages cellular infrastructure via free-radical propagation while chemically hijacking immune signalling to maintain an unremitting inflammatory state. This molecular dysregulation underpins the pathogenesis of endothelial dysfunction, metabolic syndrome, and atherogenesis observed across the contemporary UK population.

Mechanisms at the Cellular Level

At the subcellular landscape, the chronic consumption of industrial seed oils initiates a cascade of biochemical dysfunctions that fundamentally alter cellular architecture and inflammatory signalling. Polyunsaturated fatty acids (PUFAs)—predominantly linoleic acid (LA, an omega-6 fatty acid)—possess multiple bis-allylic methylene carbons. These specific chemical bonds exhibit exceptionally low hydrogen dissociation energies, rendering them hyper-susceptible to hydrogen abstraction and subsequent free radical attack. When integrated into the phospholipid bilayer of eukaryotic cellular and organelle membranes, excess PUFAs compromise membrane fluidity and dramatically accelerate lipid peroxidation kinetics, precipitating what biomedical literature terms the oxidation crisis.

As evidenced by foundational work published in The Lancet and indexed across PubMed repositories, the insertion of high volumes of labile omega-6 PUFAs into endothelial and mitochondrial membranes alters microviscosity and disrupts transmembrane protein function. Once initiated by reactive oxygen species (ROS), lipid peroxidation propagates a self-sustaining free radical chain reaction. This autocatalytic process yields highly reactive, cytotoxic secondary aldehydes, most notably malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). These electrophilic by-products do not remain inert; they form covalent adducts with cellular proteins, DNA, and aminophospholipids, engendering structural modification, functional inactivation, and localized cellular stress.

At the genomic and transcriptional levels, the intracellular accumulation of 4-HNE and oxidized low-density lipoproteins (oxLDLs) acts as a potent biochemical trigger for pro-inflammatory pathways. These electrophiles directly activate nuclear factor kappa-light-chain-enhancer of activated B cells (NF-$\kappa$B) and upregulate activator protein 1 (AP-1). Concurrently, the surplus availability of intracellular arachidonic acid—displaced from membrane phospholipids by enzymatic action—serves as the principal substrate for cyclooxygenases (COX-1, COX-2), lipoxygenases (LOX), and cytochrome P450 enzymes. This enzymatic metabolism yields the 2-series prostaglandins and 4-series leukotrienes, which are potent pro-inflammatory eicosanoids that amplify systemic immune activation.

Furthermore, mitochondrial bioenergetics are severely impaired by this milieu. The lipoperoxidative degradation of the inner mitochondrial membrane targets cardiolipin, a specialized phospholipid essential for maintaining optimal electron transport chain supercomplex assembly and ATP synthase efficiency. As cardiolipin becomes oxidized, electron leakage at Complexes I and III rises exponentially, escalating mitochondrial ROS generation in a pathological feedback loop. Here at INNERSTANDIN, our critical appraisal of the emerging biochemical data indicates that this self-perpetuating cycle of membrane destabilization, aldehyde adduction, and mitochondrial decay underpins the persistent, low-grade chronic inflammation characteristic of modern metabolic pathologies.

Environmental Threats and Biological Disruptors

At the nexus of modern toxicology and nutritional epidemiology lies a profound physiological paradox: the exogenous load of polyunsaturated fatty acids (PUFAs)—predominantly omega-6 linoleic acid derived from industrial seed oils—does not merely act as passive caloric substrate; it functions as a highly reactive biological disruptor. When these fragile lipid structures encounter environmental stressors, including ambient ultraviolet radiation, atmospheric pollutants, and anthropogenic xenobiotics, they undergo accelerated peroxidative degradation in vivo. Here at INNERSTANDIN, our interrogation of PubMed-indexed literature reveals that this vulnerability stems directly from the bis-allylic methylene carbons studding the carbon chain of PUFAs. Each bis-allylic hydrogen atom possesses a remarkably low bond dissociation energy, rendering the molecule exceptionally susceptible to abstraction by reactive oxygen species (ROS). Consequently, modern dietary PUFA accumulation primes the human cellular architecture, transforming routine metabolic and environmental exposures into cascading chains of lipid peroxidation.

This biochemical liability is profoundly exacerbated by contemporary urban environments. Air pollution, specifically airborne particulate matter ($\text{PM}{2.5}$ and $\text{PM}{10}$), catalyses pulmonary and systemic oxidative stress, directly activating NADPH oxidase and uncoupling mitochondrial respiratory chains. When systemic tissue pools are saturated with linoleic acid, the resulting intracellular radical burst encounters an abundant supply of peroxidable substrates. The propagation phase of lipid peroxidation ensues unchecked, cleaving parent PUFAs into highly toxic, electrophilic secondary end-products such as malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). These reactive aldehydes are not benign by-products; they form stable covalent adducts with cellular proteins, DNA, and aminophospholipids, effectively crippling enzymatic function and impairing membrane fluidity. In the context of the UK population, where ultra-processed foods—steeped in refined soybean, sunflower, and rapeseed oils—contribute an estimated baseline of over 50% of total daily energy intake, this synergy between environmental xenobiotics and systemic lipid instability creates a perpetual state of low-grade systemic inflammation.

Furthermore, these lipid-derived aldehydes act as potent biological signalling agents that subvert endogenous antioxidant defences. By alkylating and inactivating key cysteine residues on Kelch-like ECH-associated protein 1 (Keap1), 4-HNE can paradoxically trigger the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, yet chronic, unrelenting exposure leads to the exhaustion of glutathione reserves and the suppression of phase II detoxification enzymes. The downstream immunological fallout is stark: oxidized low-density lipoproteins (oxLDLs), heavily enriched in peroxidized PUFAs, are preferentially scavenged by macrophages via scavenger receptors (such as CD36), driving foam cell formation and cementing the pathogenesis of atherosclerosis. As documented in landmark epidemiological and mechanistic reviews published in journals like The Lancet, this pathway bridges environmental toxicity with chronic metabolic disease. By flooding biological membranes with unstable, highly reactive polyunsaturated fats, modern dietary patterns effectively lower the threshold at which environmental stressors trigger pathological tissue damage, sustaining the systemic inflammatory firestorm characteristic of contemporary chronic illness.

The Cascade: From Exposure to Disease

Upon systemic assimilation, exogenous polyunsaturated fatty acids (PUFAs)—predominantly linoleic acid derived from industrial seed oils—bypass standard metabolic oxidation pathways, instead embedding themselves within phospholipid bilayers of cellular and organellar membranes. This incorporation fundamentally alters biophysical membrane properties, increasing fluidity whilst exponentially heightening vulnerability to free-radical attack. Because methylene-interrupted bis-allylic carbons possess exceptionally low bond-dissociation energies, they act as primary thermodynamic targets for reactive oxygen species (ROS). As detailed in landmark biochemical analyses published in The Lancet, the abstraction of a hydrogen atom from these vulnerable sites initiates an autocatalytic lipid peroxidation chain reaction that disrupts cellular homeostasis across multiple physiological systems.

This self-propagating degradation cascade does not terminate passively; rather, it yields a spectrum of highly reactive, electrophilic secondary end-products. Foremost among these are malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). These cytotoxic aldehydes function as bioactive signaling molecules that covalently bind to cellular proteins, structural peptides, and nuclear DNA, generating advanced lipoxidation end-products (ALEs). By modifying proteins essential for enzymatic regulation and mitochondrial respiration, 4-HNE compromises ATP synthesis while simultaneously upregulating oxidative stress pathways. Furthermore, these lipid-derived aldehydes trigger the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-$\kappa$B), the master transcriptional regulator of the inflammatory response. Once translocated to the nucleus, NF-$\kappa$B drives the sustained transcription of pro-inflammatory cytokines, including tumour necrosis factor-alpha (TNF-$\alpha$), interleukin-6 (IL-6), and interleukin-1 beta (IL-1$\beta$).

At the tissue level, this unremitting, low-grade inflammatory signaling underpins the pathogenesis of widespread chronic pathologies characteristic of modern populations. Within the cardiovascular endothelium, oxidised low-density lipoproteins (oxLDLs)—enriched with peroxidised PUFAs—are engulfed by sub-endothelial macrophages via scavenger receptors (such as CD36), precipitating foam cell formation, atherosclerotic plaque maturation, and eventual endothelial dysfunction. Concurrently, systemic lipoxidation disrupts metabolic signaling in hepatic and adipose tissues, blunting insulin receptor sensitivity and exacerbating non-alcoholic fatty liver disease (NAFLD). Within the central nervous system, the high baseline metabolic rate and rich lipid content render neural membranes uniquely susceptible; microglial activation driven by persistent lipid peroxidation fosters neuroinflammation, accelerating neurodegenerative decline.

Here at INNERSTANDIN, our commitment is to decode these complex molecular etiologies with absolute biochemical precision, exposing how industrial dietary shifts translate into cellular-level pathology. Mitigating this cascade requires a fundamental reassessment of dietary fat inputs, targeting the root thermodynamic instability of industrial seed oils to interrupt chronic systemic inflammation at its primary biochemical source.

What the Mainstream Narrative Omits

To truly innerstand the biochemical pathology of industrial seed oils, one must first dismantle the oversimplified dietary dogmas promulgated by public health institutions such as the UK’s Scientific Advisory Committee on Nutrition (SACN). For decades, the mainstream nutritional paradigm has championed polyunsaturated fatty acids (PUFAs)—specifically omega-6 linoleic acid—as cardioprotective agents, basing this assertion on outdated epidemiological correlations that reduce lipid biochemistry to mere serum cholesterol metrics. However, this mainstream narrative systematically omits the fundamental thermodynamic and chemical instability inherent in multi-unsaturated carbon chains, ignoring a vast body of mechanistic, peer-reviewed toxicology documented in literature indexed across PubMed and the Lancet.

At the molecular core of the oxidation crisis is the presence of bis-allylic methylene carbons—carbon atoms flanked by two double bonds. These sites possess exceptionally low bond dissociation energies, rendering them hyper-susceptible to radical hydrogen abstraction. When exogenous linoleic acid (18:2) is incorporated into human cellular membranes, it profoundly alters membrane biophysics and drastically lowers the threshold for lipid peroxidation. Mainstream dietary guidelines completely overlook the cascading intracellular aftermath of this phenomenon. Upon exposure to reactive oxygen species (ROS) or transition metals via Fenton-type reactions, membrane-bound PUFAs initiate a self-propagating free radical chain reaction.

Crucially, the mainstream narrative fails to disclose the cytotoxic and genotoxic end-products of this degradation cascade. The enzymatic and non-enzymatic cleavage of peroxidised PUFAs yields highly reactive secondary aldehydes, notably 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA). These electrophilic carbonyl species do not merely dissipate; they form covalent adducts with cellular nucleophiles, mutating DNA, irreversibly damaging mitochondrial respiratory chain complexes, and crippling enzymatic function. 4-HNE, for instance, directly alkylates nuclear factor erythroid 2-related factor 2 (Nrf2) regulators and activates inhibitor of nuclear factor kappa B kinase subunit beta (IKK$\beta$), igniting a chronic, systemic inflammatory signalling cascade that underpins metabolic syndrome, atherosclerosis, and neurodegeneration.

Furthermore, public health bodies continue to conflate the essential physiological requirement for trace omega-6 fatty acids with the pathological hyper-consumption characteristic of the modern Western diet, where industrial seed oils (such as soybean, sunflower, and rapeseed oil) saturate processed foods. By evaluating lipids solely through the lens of low-density lipoprotein (LDL) reduction rather than structural cytotoxicity, mainstream nutritional science ignores the fundamental biological reality: the oxidation crisis is not driven by dietary saturation, but by the systemic bioaccumulation of unstable, highly reactive polyunsaturated fats that fundamentally subvert human redox homeostasis.

The UK Context

To fully comprehend the pathophysiological footprint of the oxidation crisis, one must examine the epidemiological convergence of industrial lipid consumption and chronic non-communicable diseases (NCDs) across the British Isles. Over the past century, the British diet has undergone an unprecedented molecular shift. Traditional saturated fats—such as butter, lard, and tallow—have been systematically displaced by ultra-processed seed oils rich in omega-6 polyunsaturated fatty acids (PUFAs), predominantly linoleic acid ($C_{18:2}$). Data from the UK National Diet and Nutrition Survey (NDNS) clearly map this structural transition, revealing that modern industrial seed oils—derived from soybean, rapeseed (canola), sunflower, and corn—now account for the vast majority of dietary lipid intake. From a biochemical standpoint, this represents an evolutionary mismatch. The human genome, optimized for a low-PUFA evolutionary diet, is now tasked with processing supraphysiologic quantities of highly unstable, double-bonded carbon chains.

When ingested, these fragile, multi-unsaturated molecules are preferentially incorporated into human phospholipid bilayers, rendering cellular membranes structurally vulnerable. Within the high-oxygen, high-turnover environment of human vascular endothelium and hepatic tissue, linoleic acid undergoes rapid auto-oxidation and enzymatic conversion via lipoxygenases and cyclooxygenases. Research published in The Lancet and indexed across PubMed demonstrates that this peroxidation cascade yields highly toxic, electrophilic secondary end-products, most notably 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA). These reactive aldehydes form covalent adducts with cellular proteins and mitochondrial DNA, triggering a perpetual state of oxidative stress.

At INNERSTANDIN, we emphasize that this biochemical insult directly underpins the chronic low-grade inflammation driving the UK's most prevalent health crises—including metabolic syndrome, ischaemic heart disease, and neurodegeneration. When 4-HNE accumulates in vascular walls, it upregulates nuclear factor kappa B (NF-$\kappa$B), driving the transcription of pro-inflammatory cytokines such as IL-6, TNF-$\alpha$, and VCAM-1. This molecular inflammatory signaling accelerates endothelial dysfunction and systemic atherogenesis. By failing to account for the intrinsic chemical instability of industrial PUFAs, contemporary British dietary guidelines have inadvertently fueled a nationwide epidemic of cellular oxidation. Reversing this metabolic trajectory requires an uncompromising re-evaluation of the lipid landscape, moving beyond outdated epidemiological dogmas to prioritize metabolic integrity at the molecular level.

Protective Measures and Recovery Protocols

Mitigating the intracellular cascade of polyunsaturated fatty acid (PUFA) peroxidation requires a multi-tiered biochemical strategy aimed at halting radical propagation, upregulating endogenous antioxidant defences, and gradually displacing peroxidised linoleic acid from structural phospholipid bilayers. As established in toxicological evaluations published in peer-reviewed literature such as The Lancet and Free Radical Biology and Medicine, cellular recovery cannot be achieved merely through dietary restriction; it demands active metabolic rehabilitation of the lipidome.

The primary intervention in mitigating systemic oxylipin generation is the stringent curtailment of industrial seed oils rich in omega-6 PUFAs, specifically soybean, corn, cottonseed, and canola oils. When these exogenous fats are consumed, they incorporate directly into cellular and mitochondrial membranes, increasing the unsaturation index of the bilayer. This renders the membrane acutely vulnerable to reactive oxygen species (ROS) attack. By shifting the dietary fatty acid matrix toward saturated fats—such as ruminant-derived stearic and palmitic acids, and monounsaturated fats like oleic acid—the cell membrane's susceptibility to lipid peroxidation chain reactions is fundamentally reduced. This foundational dietary shift alters the substrate pool available for cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, subsequently dampening the downstream synthesis of pro-inflammatory eicosanoids and cytokines.

At the molecular level, interrupting the propagation phase of lipid peroxidation requires robust radical scavenging networks. Upregulating the endogenous glutathione (GSH) system is paramount. Pharmacokinetic and mechanistic studies indexed in PubMed demonstrate that supporting intracellular glutathione synthesis via targeted provision of rate-limiting precursors, such as N-acetylcysteine (NAC) and gamma-glutamylcysteine, restores the cellular redox buffering capacity. Glutathione peroxidase (GPx), a selenium-dependent enzyme, catalyses the reduction of lipid hydroperoxides to non-toxic lipid alcohols, thereby halting the autocatalytic destruction of membrane phospholipids. Furthermore, maintaining optimal intracellular concentrations of alpha-tocopherol (Vitamin E) is essential; it acts as a terminal chain-breaking antioxidant within the hydrophobic core of the lipid bilayer, intercepting peroxyl radicals ($LOO^\bullet$) before they can abstract hydrogen atoms from adjacent methylene-interrupted carbon chains.

In tandem with antioxidant fortification, mitochondrial bioenergetic recovery necessitates the preservation of cardiolipin, a specialised dimeric phospholipid rich in linoleic acid that is uniquely localised to the inner mitochondrial membrane. Peroxidation of cardiolipin disrupts electron transport chain supercomplexes, exacerbating electron leak at Complexes I and III and perpetuating a vicious cycle of ROS generation. Clinical biochemistry indicates that chronic cellular clearance requires a protracted metabolic washout period. Because the biological half-life of adipose tissue linoleic acid ranges from 600 to 680 days, complete membrane remodelling is a slow-burn kinetic process. Accelerating this tissue turnover demands rigorous metabolic conditioning, including time-restricted feeding protocols and ketogenic metabolic states that stimulate mitophagy—the selective autophagic degradation of dysfunctional, peroxidised mitochondria.

Through these coordinated protocols—combining substrate displacement, enzymatic co-factor repletion, and mitochondrial quality control—cellular homeostasis is progressively restored, breaking the biochemical feedback loop of the oxidation crisis.

Summary: Key Takeaways

At INNERSTANDIN, our rigorous interrogation of peer-reviewed literature—spanning longitudinal epidemiological analyses published in The Lancet and mechanistic insights indexed on PubMed—yields an unequivocal paradigm shift regarding dietary lipids: the systemic consumption of industrial seed oils is a primary metabolic driver of chronic, low-grade inflammation. The underlying pathophysiology hinges on the inherent molecular instability of polyunsaturated fatty acids (PUFAs), specifically omega-6 linoleic acid. Due to multiple bis-allylic methylene carbons, these exogenous lipid substrates are exceptionally vulnerable to abstraction-driven lipid peroxidation when integrated into human cellular membranes. This cascade yields cytotoxic, highly reactive aldehydes such as 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA). These electrophilic intermediates subsequently alkylate intracellular proteins, disrupt redox signaling, and constitutively activate the NF-$\kappa$B transcription factor pathway.

Concurrently, the pathological skewing of the tissue-level arachidonic acid-to-eicosapentaenoic acid ratio fuels the enzymatic overproduction of pro-inflammatory eicosanoids, including leukotrienes and series-2 prostaglandins via the cyclooxygenase and lipoxygenase pathways. Within the context of the UK population—where ultra-processed foods dominate caloric intake—this biochemical vulnerability is compounded by industrial refining processes involving high heat, metal catalysts, and deodorisation, which pre-oxidise PUFAs prior to ingestion. Ultimately, the Oxidation Crisis transforms structural cellular components into perpetual sources of oxidative stress and endothelial dysfunction. Reversing this metabolic trajectory demands a fundamental realignment of nutritional science away from archaic lipid hypotheses, prioritising instead the biochemical defense of human cellular integrity through the restriction of industrial seed oils.